Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-25

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Methylphenidate Hydrochloride CD from Lannett Company, Inc. The approval indicates an updated or added aspect to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)